Your browser doesn't support javascript.
loading
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
Rusert, Jessica M; Juarez, Edwin F; Brabetz, Sebastian; Jensen, James; Garancher, Alexandra; Chau, Lianne Q; Tacheva-Grigorova, Silvia K; Wahab, Sameerah; Udaka, Yoko T; Finlay, Darren; Seker-Cin, Huriye; Reardon, Brendan; Gröbner, Susanne; Serrano, Jonathan; Ecker, Jonas; Qi, Lin; Kogiso, Mari; Du, Yuchen; Baxter, Patricia A; Henderson, Jacob J; Berens, Michael E; Vuori, Kristiina; Milde, Till; Cho, Yoon-Jae; Li, Xiao-Nan; Olson, James M; Reyes, Iris; Snuderl, Matija; Wong, Terence C; Dimmock, David P; Nahas, Shareef A; Malicki, Denise; Crawford, John R; Levy, Michael L; Van Allen, Eliezer M; Pfister, Stefan M; Tamayo, Pablo; Kool, Marcel; Mesirov, Jill P; Wechsler-Reya, Robert J.
Afiliação
  • Rusert JM; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Juarez EF; Department of Medicine, University of California San Diego, La Jolla, California.
  • Brabetz S; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Jensen J; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Garancher A; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Chau LQ; Department of Medicine, University of California San Diego, La Jolla, California.
  • Tacheva-Grigorova SK; Moores Cancer Center, University of California San Diego, La Jolla, California.
  • Wahab S; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Udaka YT; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Finlay D; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Seker-Cin H; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Reardon B; Rady Children's Hospital San Diego, San Diego, California.
  • Gröbner S; Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Serrano J; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Ecker J; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Qi L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Kogiso M; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
  • Du Y; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Baxter PA; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Henderson JJ; Department of Pathology, NYU Langone Health, New York, New York.
  • Berens ME; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Vuori K; CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Milde T; Department of Pediatric Oncology and Hematology, University Hospital Heidelberg, Heidelberg, Germany.
  • Cho YJ; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Li XN; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Olson JM; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Reyes I; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, Illinois.
  • Snuderl M; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Wong TC; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, Illinois.
  • Dimmock DP; Papé Family Pediatric Research Institute, Department of Pediatrics, and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Nahas SA; Cancer and Cell Biology Division, The Translational Genomics Research Institute, Phoenix, Arizona.
  • Malicki D; Tumor Microenvironment and Cancer Immunology Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.
  • Crawford JR; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Levy ML; CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Van Allen EM; Department of Pediatric Oncology and Hematology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pfister SM; Papé Family Pediatric Research Institute, Department of Pediatrics, and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
  • Tamayo P; Brain Tumor Program, Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Kool M; Program of Precision Medicine PDOX Modeling of Pediatric Tumors, Ann & Robert H. Lurie Children's Hospital of Chicago, Department of Pediatrics, Northwestern University, Chicago, Illinois.
  • Mesirov JP; Fred Hutchinson Cancer Research Center and Seattle Children's Hospital, Seattle, Washington.
  • Wechsler-Reya RJ; Rady Children's Institute for Genomic Medicine, San Diego, California.
Cancer Res ; 80(23): 5393-5407, 2020 12 01.
Article em En | MEDLINE | ID: mdl-33046443
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Medicina de Precisão / Meduloblastoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Child / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Medicina de Precisão / Meduloblastoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Child / Humans / Male Idioma: En Revista: Cancer Res Ano de publicação: 2020 Tipo de documento: Article